HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meng-Shan Li Selected Research

Ischemia

8/2022Response to belimumab in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a case-based review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meng-Shan Li Research Topics

Disease

2Pleural Effusion (Pleural Effusions)
08/2022 - 04/2022
2Thrombocytopenia (Thrombopenia)
08/2022 - 04/2022
1Hemolytic Anemia
08/2022
1Ischemia
08/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2022
1Purpura
08/2022
1Thrombotic Thrombocytopenic Purpura
08/2022
1Leukopenia
04/2022
1Tuberculosis (Tuberculoses)
04/2022
1Cytopenia
04/2022
1Fever (Fevers)
04/2022
1Stroke (Strokes)
01/2014

Drug/Important Bio-Agent (IBA)

1thiamine triphosphorate (TTP)IBA
08/2022
1belimumabIBA
08/2022
1Complement C3 (C3 Complement)IBA
08/2022
1Hemoglobins (Hemoglobin)IBA
08/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2022
1Antinuclear AntibodiesIBA
04/2022
1Proteins (Proteins, Gene)FDA Link
04/2022
1GlucocorticoidsIBA
04/2022
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
04/2022
1fibrin fragment D (D-dimer)IBA
01/2014